182 related articles for article (PubMed ID: 30231387)
1. Incorporating Genomics Into the Care of Patients With Advanced Breast Cancer.
Kratz J; Burkard M; O'Meara T; Pusztai L; Veitch Z; Bedard PL
Am Soc Clin Oncol Educ Book; 2018 May; 38():56-64. PubMed ID: 30231387
[TBL] [Abstract][Full Text] [Related]
2. Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centers.
Santa-Maria CA; Kruse M; Raska P; Weiss M; Swoboda A; Mutonga MB; Abraham J; Jain S; Nanda R; Montero AJ
Breast Cancer Res Treat; 2017 Nov; 166(1):179-184. PubMed ID: 28752189
[TBL] [Abstract][Full Text] [Related]
3. Integrating clinicopathologic and genomic tools in chemotherapy decision-making for early stage breast cancer.
Havard R; Henry NL
Future Oncol; 2017 Dec; 13(28):2507-2510. PubMed ID: 29168654
[No Abstract] [Full Text] [Related]
4. Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
Ross JS; Gay LM; Wang K; Ali SM; Chumsri S; Elvin JA; Bose R; Vergilio JA; Suh J; Yelensky R; Lipson D; Chmielecki J; Waintraub S; Leyland-Jones B; Miller VA; Stephens PJ
Cancer; 2016 Sep; 122(17):2654-62. PubMed ID: 27284958
[TBL] [Abstract][Full Text] [Related]
5. Molecular Genomic Testing for Breast Cancer: Utility for Surgeons.
Fayanju OM; Park KU; Lucci A
Ann Surg Oncol; 2018 Feb; 25(2):512-519. PubMed ID: 29159748
[TBL] [Abstract][Full Text] [Related]
6. Emerging Role of Genomics and Cell-Free DNA in Breast Cancer.
Gerratana L; Davis AA; Shah AN; Lin C; Corvaja C; Cristofanilli M
Curr Treat Options Oncol; 2019 Jun; 20(8):68. PubMed ID: 31256282
[TBL] [Abstract][Full Text] [Related]
7. Precision Medicine in Breast Cancer.
Odle TG
Radiol Technol; 2017 Mar; 88(4):401M-421M. PubMed ID: 28298516
[TBL] [Abstract][Full Text] [Related]
8. Translational Genomics: Practical Applications of the Genomic Revolution in Breast Cancer.
Yates LR; Desmedt C
Clin Cancer Res; 2017 Jun; 23(11):2630-2639. PubMed ID: 28572257
[TBL] [Abstract][Full Text] [Related]
9. Genomic Pathology and Biomarkers in Breast Cancer.
Zhang Z; Tang P
Crit Rev Oncog; 2017; 22(5-6):411-426. PubMed ID: 29604921
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of routine genomic mutation sequencing in PIK3CA/AKT1 and KRAS/NRAS/BRAF in metastatic breast cancer.
Cejalvo JM; Pérez-Fidalgo JA; Ribas G; Burgués O; Mongort C; Alonso E; Ibarrola-Villava M; Bermejo B; Martínez MT; Cervantes A; Lluch A
Breast Cancer Res Treat; 2016 Nov; 160(1):69-77. PubMed ID: 27628192
[TBL] [Abstract][Full Text] [Related]
11. Initial experience with genomic profiling of heavily pretreated breast cancers.
Staren ED; Braun D; Tan B; Gupta D; Kim S; Kramer K; Markman M
Ann Surg Oncol; 2014 Oct; 21(10):3216-22. PubMed ID: 25047475
[TBL] [Abstract][Full Text] [Related]
12. Clinical application of high-throughput genomic technologies for treatment selection in breast cancer.
Hansen AR; Bedard PL
Breast Cancer Res; 2013; 15(5):R97. PubMed ID: 24135425
[TBL] [Abstract][Full Text] [Related]
13. Molecular Testing in Breast Cancer.
Litton JK; Burstein HJ; Turner NC
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e1-e7. PubMed ID: 31099622
[TBL] [Abstract][Full Text] [Related]
14. Standard and Genomic Tools for Decision Support in Breast Cancer Treatment.
Henry NL; Bedard PL; DeMichele A
Am Soc Clin Oncol Educ Book; 2017; 37():106-115. PubMed ID: 28561710
[TBL] [Abstract][Full Text] [Related]
15. Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer.
Pezo RC; Chen TW; Berman HK; Mulligan AM; Razak AA; Siu LL; Cescon DW; Amir E; Elser C; Warr DG; Sridhar SS; Yu C; Wang L; Stockley TL; Kamel-Reid S; Bedard PL
Breast Cancer Res Treat; 2018 Feb; 168(1):159-168. PubMed ID: 29177603
[TBL] [Abstract][Full Text] [Related]
16. Development of diagnostic SCAR markers for genomic DNA amplifications in breast carcinoma by DNA cloning of high-GC RAMP-PCR fragments.
Fu S; Cheng J; Wei C; Yang L; Xiao X; Zhang D; Stewart MD; Fu J
Oncotarget; 2017 Jul; 8(27):43866-43877. PubMed ID: 28410206
[TBL] [Abstract][Full Text] [Related]
17. [Genomics and clinical research for breast cancer].
Bertucci F; Birnbaum D
Med Sci (Paris); 2012 Mar; 28 Spec No 1():14-8. PubMed ID: 22494651
[TBL] [Abstract][Full Text] [Related]
18. How to manage patients with moderate-risk germline mutations.
Tung NM
Clin Adv Hematol Oncol; 2018 Feb; 16(2):97-101. PubMed ID: 29741508
[No Abstract] [Full Text] [Related]
19. Breast Cancer: A Molecular and Redox Snapshot.
Raman D; Foo CH; Clement MV; Pervaiz S
Antioxid Redox Signal; 2016 Aug; 25(6):337-70. PubMed ID: 27116998
[TBL] [Abstract][Full Text] [Related]
20. Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
Gradishar WJ; Anderson BO; Abraham J; Aft R; Agnese D; Allison KH; Blair SL; Burstein HJ; Dang C; Elias AD; Giordano SH; Goetz MP; Goldstein LJ; Isakoff SJ; Krishnamurthy J; Lyons J; Marcom PK; Matro J; Mayer IA; Moran MS; Mortimer J; O'Regan RM; Patel SA; Pierce LJ; Rugo HS; Sitapati A; Smith KL; Smith ML; Soliman H; Stringer-Reasor EM; Telli ML; Ward JH; Young JS; Burns JL; Kumar R
J Natl Compr Canc Netw; 2020 Apr; 18(4):452-478. PubMed ID: 32259783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
